1. Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study.
- Author
-
Sharad B, Eckerdal N, Magnusson M, Michelsen HÖ, Jujic A, Lidin M, Mellbin L, Shaat N, Pingel R, Wallert J, Hagström E, and Leósdóttir M
- Subjects
- Humans, Male, Female, Middle Aged, Sweden epidemiology, Aged, Treatment Outcome, Time Factors, Predictive Value of Tests, Glycemic Control, Health Care Surveys, Practice Patterns, Physicians', Blood Glucose metabolism, Blood Glucose drug effects, Myocardial Infarction diagnosis, Myocardial Infarction rehabilitation, Myocardial Infarction therapy, Myocardial Infarction epidemiology, Myocardial Infarction blood, Registries, Cardiac Rehabilitation, Glucose Tolerance Test, Hypoglycemic Agents therapeutic use, Glycated Hemoglobin metabolism, Diabetes Mellitus diagnosis, Diabetes Mellitus epidemiology, Diabetes Mellitus blood, Diabetes Mellitus therapy, Biomarkers blood
- Abstract
Background: Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations between structured diabetes care routines in cardiac rehabilitation (CR) and detection and treatment of diabetes at one-year post-MI., Methods: Center-level data was derived from the Perfect-CR survey, which evaluated work routines applied at Swedish CR centers (n = 76). Work routines involving diabetes care included: (1) routine assessment of fasting glucose and/or HbA1c, (2) routine use of oral glucose tolerance test (OGTT), (3) having regular case rounds with diabetologists, and (4) whether glucose-lowering medication was adjusted by CR physicians. Patient-level data was obtained from the national MI registry SWEDEHEART (n = 7601, 76% male, mean age 62.6 years) and included all post-MI patients irrespective of diabetes diagnosis. Using mixed-effects regression we estimated differences between patients exposed versus. not exposed to the four above-mentioned diabetes care routines. Outcomes were newly detected diabetes and the proportion of patients receiving oral glucose-lowering medication at one-year post-MI., Results: Routine assessment of fasting glucose/HbA1c was performed at 63.2% (n = 48) of the centers, while 38.2% (n = 29) reported using OGTT for detecting glucose abnormalities. Glucose-lowering medication adjusted by CR physicians (n = 13, 17.1%) or regular case rounds with diabetologists (n = 7, 9.2%) were less frequently reported. In total, 4.0% of all patients (n = 304) were diagnosed with diabetes during follow-up and 17.9% (n = 1361) were on oral glucose-lowering treatment one-year post-MI. Routine use of OGTT was associated with a higher rate of newly detected diabetes at one-year (risk ratio [95% confidence interval]: 1.62 [1.26, 1.98], p = 0.0007). At one-year a higher proportion of patients were receiving oral glucose-lowering medication at centers using OGTT (1.22 [1.07, 1.37], p = 0.0046) and where such medication was adjusted by CR physicians (1.31 [1.06, 1.56], p = 0.0155). Compared to having none of the structured diabetes care routines, the more routines implemented the higher the rate of newly detected diabetes (from 0 routines: 2.7% to 4 routines: 6.3%; p for trend = 0.0014)., Conclusions: Having structured routines for diabetes care implemented within CR can improve detection and treatment of diabetes post-MI. A cluster-randomized trial is warranted to ascertain causality., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF